Senior Manager, Equity Administration & Payroll

Eikon Therapeutics; Millbrae (CA); On-site; USD 145,000 - 158,650; Full time

Job summary

Eikon Therapeutics, located in Millbrae, CA, is looking for a Senior Manager, Stock Administration and Payroll. In this pivotal role, you will lead payroll and stock administration functions, ensuring compliance and operational effectiveness, especially as the company gears up for public operations.

The ideal candidate will have extensive experience in payroll and equity program administration within a high-growth environment. This position offers a compelling opportunity to influence systems and processes in a dynamic biopharmaceutical setting.

Qualifications

• 12+ years of experience, or 10+ years with post-graduate degree in related functions.
• Strong payroll processing experience with a knowledge of operations and audits.
• Experience in high-growth public company environments administering equity compensation.

Responsibilities

• Lead end-to-end payroll processing to ensure accuracy and compliance.
• Oversee stock administration functions covering all equity lifecycle activities.
• Partner with Finance, HR, Legal, and vendors to ensure accurate reconciliations.

Skills

Payroll processing

Equity compensation administration

Compliance and auditing

Communication skills

Analytical skills

Education

Bachelor’s degree or post-graduate degree in Finance, HR, or related discipline

Tools

E*TRADE (Equity Edge Online)

SAP SuccessFactors

Job description

Eikon Therapeutics, located in Millbrae, CA, is looking for a Senior Manager, Stock Administration and Payroll. In this pivotal role, you will lead payroll and stock administration functions, ensuring compliance and operational effectiveness, especially as the company gears up for public operations.

The ideal candidate will have extensive experience in payroll and equity program administration within a high-growth environment. This position offers a compelling opportunity to influence systems and processes in a dynamic biopharmaceutical setting.